008730 — Youlchon Chemical Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩807bn
- KR₩1tn
- KR₩414bn
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 20,030 | 33,177 | 67,237 | 37,687 | 47,151 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 128,146 | 125,903 | 124,837 | 115,291 | 115,686 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 208,445 | 219,413 | 269,088 | 237,342 | 260,351 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 371,297 | 374,188 | 379,252 | 384,373 | 396,915 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 606,491 | 613,345 | 666,716 | 653,136 | 678,951 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 129,920 | 159,793 | 169,610 | 139,457 | 274,039 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 264,508 | 265,701 | 320,650 | 319,324 | 372,689 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 341,984 | 347,643 | 346,066 | 333,812 | 306,262 |
Total Liabilities & Shareholders' Equity | 606,491 | 613,345 | 666,716 | 653,136 | 678,951 |
Total Common Shares Outstanding |